SmithKline Beecham Polio vaccine - New presentation

被引：0

|

作者：

不详

机构：

来源：

IRISH MEDICAL JOURNAL | 1999年 / 92卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：347 / 347

页数：1

相关论文

共 50 条

[41] Merger talks held by American Home, SmithKline Beecham
不详
CHEMICAL & ENGINEERING NEWS, 1998, 76 (04) : 14 - 14
[42] Smithkline Beecham - Europe lifts ban on diabetes drug
不详
CHEMISTRY & INDUSTRY, 2000, (07) : 239 - 239
[43] DTaP-hepatitis B-poliovirus vaccine (SmithKline Beecham). InfanrixDTPa-HepB-IPV.
不详
Drugs in R & D, 1999, 2 (3) : 195 - 196
[44] A new polio vaccine?
Cello, J
De Jesus, N
Chumakov, K
Yin, J
Paul, AV
Gromeier, M
Wimmer, E
VACCINES: PREVENTING DISEASE AND PROTECTING HEALTH, 2004, (596): : 183 - 188
[45] Merger of Glaxo Wellcome and SmithKline Beecham creates pharmaceutical giant
Alison Abbott
Nature, 2000, 403 : 232 - 232
[46] SmithKline Beecham's drug-testing lab in Atlanta
Chemical & Engineering News, 1996, 74 (26):
[47] Merger of Glaxo Wellcome and SmithKline Beecham creates pharmaceutical giant
Abbott, A
NATURE, 2000, 403 (6767) : 232 - 232
[48] Glaxo Wellcome and SmithKline Beecham to merge in £100b deal
不详
CHEMICAL ENGINEER-LONDON, 1998, (651): : 4 - 4
[49] SmithKline Beecham funds Stanford University Program in Genomics, Ethics, and Society
不详
BIOTECHNOLOGY LAW REPORT, 1996, 15 (01): : 62 - 62
[50] How SmithKline Beecham makes better resource-allocation decisions
Sharpe, P
Keelin, T
HARVARD BUSINESS REVIEW, 1998, 76 (02) : 45 - +

← 1 2 3 4 5 →